Tate Feeney, PharmD, BCOP

Noticed a high rate of IPS(19%, with 3 deaths) in the recent fractionated busulfan article. Was this consider regimen related? The haematologica 2022 article (PMID: 35770531) also has 1 death from IPS. @AlisonGulbis @ASTCT #twitteRx #HemOnc #Oncopharm pubmed.ncbi.nlm.nih.gov/37611156/

Organ and tissue transplantation is known to save lives, but it brings disadvantages, too. specialtypharmacycontinuum.com/Clinical/Artic… @FeeneyTate @MSKCancerCenter

learning how to fluidly pronounce “omidubicel” + immunotherapy updates from the ASH 2022 meeting from @FeeneyTate! #Tandem23 @ASTCT @CIBMTR

Opus Number 1 youtu.be/w-SIManm_Qo via @YouTube Absolute banger. #TwitteRx

Paving the Road for CAR-Ts: ASTCT 80/20 Task Force consensus for IECs published yesterday!! #ASTCT #TwitteRx #HemOnc 🙏😭🤤 astctjournal.org/article/S2666-…

@JessieSig @KPsiBCOP Not sure why it is not in the PI of all solid dosage forms. I am sure it is reviewed by the FDA at some point in the approval process. But is not given to the end users. Maybe we should create our own “Lexi-Comp” of pill sizes?🤔 It would be extremely useful for many

@KPsiBCOP I mean size as in measurement example “5 cm wide and long” so we know if a patient is going to be able to swallow it 😩 I felt like a real loon calling a specialty pharmacy to ask them to describe the size today for a patient with difficult swallowing 😑

How do we get prescribing information to include the size of a tablet, especially oral chemo 🤔 #oncopharm #pharmacy

The never-ending story of in vivo T-cell depletion continues. "ATG in HLA-matched, peripheral blood, hematopoietic cell transplantation in AML and MDS: a secondary analysis of a CIBMTR database" sciencedirect.com/science/articl… #TwitteRx #ASTCT @ASTCT_Journal @ASTCT #oncopharm

Great read this morning. "Outcomes of CD19 targeted CAR T-cell Therapy for Patients with Reduced Renal Function Including Dialysis" sciencedirect.com/science/articl… @ChristinaBachRx @MoffittNews @ASTCT @ASTCT_Journal #TwitteRx #Oncopharm #CellularTherapy

Excited to share our pre-clinical mouse work showing efficacy of JAK1/2 inhibition in immune marrow failure published in @BloodJournal. Our work is the basis for an upcoming @nih_nhlbi @NIHClinicalCntr clinical trial using ruxolitinib in immune #BMFsm 1/4. sciencedirect.com/science/articl…

@LordLsWizzle Miss you guys too!! Say hi to everyone at @WilmotCancer for me!

I got out of the iv room cause we AP for tomorrow & I just wanna see @FeeneyTate

Efficacy of JAK 1/2 inhibition in murine immune bone marrow failure ashpublications.org/blood/article-… Been thinking about this since #TCT2022. Cool to see the basic science point to the efficacy of JAK inhibition in SAA. Also can RUX-CHOW be a thing now? #Oncopharm #Blood #SAA

Tweetorial for new and old practitioners: How to efficiently stay up to date with literature. 🤓 1/11

12/11??? Like starting any new habit you don’t need to be perfect, just have fun with it. This is for you, so anything you do is better than nothing.

11/11 SAVE YOUR ARTICLES. Create an organized system and save the articles in a way that will allow you to access them again. You will be surprised how quickly your library will grow and the helpful info it will contain.

10/11 Be consistent. This is the key to success. Start with something you could easily work into your schedule. Even 5-15 minutes 2-3 times per weeks adds up fast. I get to work a few minutes early and start my day with some peaceful literature.

9/11 New drugs on Lexi/new FDA approvals. See what is being approved, and never be caught-off guard with what a new drug is. Ask yourself if these new medications would benefit your patients, or which of your patients they would benefit the most from some new drug?

8/11 Use a text-to-speech to turn any journal article into a podcast/audiobook. Great for reviewing literature when your hands are tided up, but your ears are free. I use the “Spoken Content” function on my iPhone

7/11 Find relevant podcasts that review/discuss recent publication or updates. Listen to free “journal club” presented by subject matter experts while you drive, exercise, and/or do household chores. Might I recommend the amazing @WolverHeme

6/11 Use pubmed trending. You will encounter a diverse set of literature and find new high impact journals. I usually sort by recent, and look at the first 100 articles about once per week.

5/11 Include both clinical and basic science/translation medicine journals. Often these journals are 1-2 steps ahead of or supporting recent updates. This ensures you understand the biologic rationale for the most recent updates and their limitations